Month: June 2020

Aspocomp Group Oyj, Johdon liiketoimet, 22.6.2020 klo 8.30____________________________________________IlmoitusvelvollinenNimi: Joensuun Kauppa ja Kone OyAsema: Lähipiiriin kuuluva henkilö(X) Oikeushenkilö

Quadient Announces New Parcel Locker Lite™ Solution to Disrupt Parcel Delivery Landscape, Achieving New Milestone of its Strategic PlanQuadient combines years of experience in retail and shipping with the expertise and experience of recently acquired Parcel PendingThe Parcel Pending Lite™ innovation will bring automated parcel pickup to shops of all sizesCommitment to roll-out 3,000 units in Japan over the next three years starting as soon as this summerParis, June 22, 2020Quadient, a leader in helping businesses create meaningful customer connections through digital and physical channels, announced today the global launch of new compact and modular parcel lockers, designed to facilitate the roll-out and accelerate adoption of parcel locker delivery and automated pickup solutions in the retail and parcel carrier markets.  The need for...

Quadient annonce sa nouvelle consigne colis Lite, nouvelle étape de son plan stratégique, qui vient bouleverser le paysage de la livraison et du retrait de colisQuadient conjugue ses années d’expérience auprès des acteurs de la distribution et du transport de colis avec le savoir-faire et l’expérience de Parcel Pending, sa plus récente acquisitionParcel Pending Lite est une innovation qui va donner accès au retrait de colis automatisé aux commerces de toutes taillesLe déploiement de 3 000 unités déjà confirmé au Japon à partir de cet été et sur les trois prochaines annéesParis, le 22 juin 2020Quadient, un leader des solutions d’entreprise visant à faire de chaque interaction client – via un canal physique ou digital – une expérience riche et personnalisée, annonce aujourd’hui le lancement mondial de consignes à colis compactes...

Polarcus Limited (“Polarcus” or the “Company”) (OSE: PLCS) refers to its press release dated 31 March 2020 which provided details of enhanced business continuity measures and a USD 15 million cost reduction plan to navigate the market uncertainty caused by the combined impact of the COVID-19 pandemic and oil price volatility. A program of further action has been implemented to streamline the organisation and adjust operational capacity to align with current market conditions and the near-term outlook, while preserving the Company’s established foundations.The Polarcus client-facing organization has been reshaped into an efficient and more scalable hemisphere structure. Sales and marketing presence will be maintained in Houston and London (Western Hemisphere) and in Dubai and Singapore (Eastern Hemisphere). In addition,...

EfTEN Real Estate Fund III AS (trading code EFT1T, ISIN kood EE3100127242) will close the list of shareholders for dividend payment on 07.07.2020 at the end of of the working day of the registrar of the settlement system of the fund’s securities.Proceeding from the above, the ex-date is 06.07.2020. From that date the new owner of the shares is not entitled to dividends for the year 2019.EfTEN Real Estate Fund III AS will pay dividend 65 euro cents per share on 10.07.2020.Viljar ArakasMember of the Management BoardPhone 655 9515E-mail: viljar.arakas@eften.ee

EfTEN Real Estate Fund III AS-i (väärtpaberi lühinimi EFT1T, ISIN kood EE3100127242) fikseerib aktsionäride nimekirja dividendi maksmiseks 07.07.2020 väärtpaberite registripidaja arveldussüsteemi tööpäeva lõpu seisuga. Ülaltoodust lähtudes on väärtpaberitega seotud õiguste muutumise päev (ex-päev) 06.07.2020. Alates sellest kuupäevast ei ole aktsiad omandanud isik õigustatud saama dividende 2019. majandusaasta eest.EfTEN Real Estate Fund III AS maksab aktsionäridele dividendi 65 eurosenti 10.07.2020.Viljar Arakasjuhatuse liigeTel. 655 9515E-post: viljar.arakas@eften.ee

Basel, Switzerland, June 22, 2020Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that it has received a CHF 5 million milestone payment from its license partner Pfizer Inc. (NYSE: PFE, “Pfizer”). The milestone was triggered by the granting of the marketing authorization for the antifungal Cresemba® (isavuconazole) in the Russian Federation.David Veitch, Chief Executive Officer, said: “We are very pleased that physicians in Russia will soon be able to prescribe Cresemba for their patients with invasive mold infections. This approval is an important milestone in the global commercial roll-out of the brand, as Russia is one of the commercially most important markets outside of China, the EU and the U.S.”In Russia, oral Cresemba is approved in adults for the treatment of invasive aspergillosis and the treatment of mucormycosis in adult...

Basel, 22. Juni 2020Basilea Pharmaceutica AG (SIX: BSLN) gab heute bekannt, dass sie von ihrem Lizenzpartner Pfizer Inc. (NYSE: PFE, “Pfizer”) eine Meilensteinzahlung von CHF 5 Mio. erhalten hat. Auslöser der Meilensteinzahlung war die Erteilung der Marktzulassung für das Antimykotikum Cresemba® (Isavuconazol) in der Russischen Föderation.David Veitch, Chief Executive Officer von Basilea, sagte: „Wir freuen uns sehr, dass Ärzte in Russland ihren Patienten mit invasiven Schimmelpilzinfektionen bald Cresemba verschreiben können. Die Zulassung ist ein wichtiger Meilenstein in der globalen Vermarktung des Medikaments, da Russland einer der kommerziell wichtigsten Märkte ausserhalb von China, der EU und den USA ist.“In Russland ist orales Cresemba für die Behandlung von erwachsenen Patienten mit invasiver Aspergillose zugelassen und für die...

VANCOUVER, British Columbia, June 21, 2020 (GLOBE NEWSWIRE) — SouthGobi Resources Ltd. (TSX: SGQ, HK: 1878) (“SouthGobi” or the “Company”) announces that the British Columbia Securities Commission has issued a general “failure to file” cease trade order (“CTO”) on June 19, 2020 (Vancouver time), to prohibit the trading by any person of any securities of the Company in Canada. Trading in the Company’s common shares on the TSX has been halted as a result of the CTO.Reference is made to the announcement of the Company dated June 11, 2020 (“Announcement”). Unless the context otherwise requires, capitalized terms used herein shall have the same meanings as those defined in the Announcement.The CTO was issued as of result the Company’s failure to file its the 2019 Annual Filings and its 2020 Interim Filings by the filing deadline of June...

FORT WORTH, Texas, June 21, 2020 (GLOBE NEWSWIRE) — American Airlines, Inc. (NASDAQ: AAL) (the “Company”) today announced a proposed private offering of $1.5 billion aggregate principal amount of secured senior notes due 2025 (the “Notes”). The Notes will be guaranteed on a senior unsecured basis by American Airlines Group Inc. (the “Guarantor”). The Company also announced it intends to enter into a new $500 million Term Loan B Facility due 2024 (the “Term Loan”) concurrently with the closing of the offering of the Notes.The Company expects to use a portion of the net proceeds from the offering of the Notes and borrowings under the Term Loan to refinance its delayed draw term loan facility which the Company and the Guarantor entered into on March 18, 2020 and is scheduled to mature on March 17, 2021, with the remainder for general...